Archives for October 22, 2024

← 2024

PTC Therapeutics’ Translarna misses European regulatory hurdle again

22-Oct-2024

By Jonathan Smith

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has once again snubbed Translarna (ataluren), PTC Therapeutics’ treatment for the genetic disease Duchenne muscular dystrophy (DMD).

Seaport Therapeutics closes $225 million Series B to develop neuropsychiatric drugs

22-Oct-2024

By Helen Albert

The Boston-based biotech will use the new fundraise to develop its pipeline of drug candidates for conditions such as major depressive disorder and generalized anxiety disorder.